Document Detail


Importance of the interaction protein-protein of the CaM-PDE1A and CaM-MLCK complexes in the development of new anti-CaM drugs.
MedLine Citation:
PMID:  23456740     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Protein-protein interactions play central roles in physiological and pathological processes. The bases of the mechanisms of drug action are relevant to the discovery of new therapeutic targets. This work focuses on understanding the interactions in protein-protein-ligands complexes, using proteins calmodulin (CaM), human calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A active human (PDE1A), and myosin light chain kinase (MLCK) and ligands αII-spectrin peptide (αII-spec), and two inhibitors of CaM (chlorpromazine (CPZ) and malbrancheamide (MBC)). The interaction was monitored with a fluorescent biosensor of CaM (hCaM M124C-mBBr). The results showed changes in the affinity of CPZ and MBC depending on the CaM-protein complex under analysis. For the Ca(2+) -CaM, Ca(2+) -CaM-PDE1A, and Ca(2+) -CaM-MLCK complexes, CPZ apparent dissociation constants (Kds ) were 1.11, 0.28, and 0.55 μM, respectively; and for MBC Kds were 1.43, 1.10, and 0.61 μM, respectively. In competition experiments the addition of calmodulin binding peptide 1 (αII-spec) to Ca(2+) -hCaM M124C-mBBr quenched the fluorescence (Kd  = 2.55 ± 1.75 pM) and the later addition of MBC (up to 16 μM) did not affect the fluorescent signal. Instead, the additions of αII-spec to a preformed Ca(2+) -hCaM M124C-mBBr-MBC complex modified the fluorescent signal. However, MBC was able to displace the PDE1A and MLCK from its complex with Ca(2+) -CaM. In addition, docking studies were performed for all complexes with both ligands showing an excellent correlation with experimental data. These experiments may help to explain why in vivo many CaM drugs target prefer only a subset of the Ca(2+) -CaM regulated proteins and adds to the understanding of molecular interactions between protein complexes and small ligands.
Authors:
Martin González-Andrade; Rachel Mata; Abraham Madariaga-Mazón; Rogelio Rodríguez-Sotres; Luis Del Pozo-Yauner; Alejandro Sosa-Peinado
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of molecular recognition : JMR     Volume:  26     ISSN:  1099-1352     ISO Abbreviation:  J. Mol. Recognit.     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-03-04     Completed Date:  2013-08-09     Revised Date:  2013-08-19    
Medline Journal Info:
Nlm Unique ID:  9004580     Medline TA:  J Mol Recognit     Country:  England    
Other Details:
Languages:  eng     Pagination:  165-74     Citation Subset:  IM    
Copyright Information:
Copyright © 2013 John Wiley & Sons, Ltd.
Affiliation:
Instituto Nacional de Medicina Genómica, Secretaría de Salud, México DF, 14610, México. mgonzalez@inmegen.gob.mx
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Calcium / chemistry
Calmodulin / antagonists & inhibitors,  chemistry*
Chlorpromazine / chemistry*
Cyclic Nucleotide Phosphodiesterases, Type 1 / chemistry*
Drug Discovery
Humans
Indole Alkaloids / chemistry*
Molecular Docking Simulation
Myosin-Light-Chain Kinase / chemistry*
Protein Binding
Spectrometry, Fluorescence
Chemical
Reg. No./Substance:
0/Calmodulin; 0/Indole Alkaloids; 0/malbrancheamide; 50-53-3/Chlorpromazine; 7440-70-2/Calcium; EC 2.7.11.18/Myosin-Light-Chain Kinase; EC 3.1.4.17/Cyclic Nucleotide Phosphodiesterases, Type 1; EC 3.1.4.17/PDE1A protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chiral discrimination and interaction mechanism between enantiomers and serum albumins.
Next Document:  Opening dynamics of 8-oxoguanine in DNA.